Form 4: Zimmer Biomet Executive Bezjak Reports Stock Transactions

Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reports acquisition and disposal of common stock and restricted stock units.

Summary

• On February 18, 2025, Mark Bezjak acquired 7,865 shares of Zimmer Biomet common stock upon the vesting of restricted stock units (RSUs).
• These RSUs were granted on February 18, 2022, and their vesting was contingent upon meeting certain performance conditions over the period of 2022-2024.
• Bezjak also disposed of 1,954 shares to satisfy tax withholding obligations related to the vesting of the RSUs at a price of $101.
• Additionally, he acquired 57 shares under the Employee Stock Purchase Plan.
• Following these transactions, Bezjak directly owns 10,326 shares of common stock and 0 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and does not inherently indicate positive or negative company performance.

Positives

• The vesting of RSUs indicates that performance conditions were met, suggesting positive performance during the 2022-2024 period.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in stock transactions by company insiders. This filing provides insight into the executive's holdings and recent transactions, which can be of interest to investors.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect insider activity related to compensation.

Key Dates